Preventing Urinary Tract Infection Post-Surgery
Completed · Phase 2 · Has a placebo group
Conditions studied: Urinary Tract Infection
In brief
Approximately 10-27% of patients undergoing gynecologic surgeries develop a catheter associated urinary tract infection (CAUTI) in the post operatory period, as bladder catheterization is a common practice in gynecologic surgery. Cranberry products provide alternative means for preventing CAUTI and could result in decreased use of antimicrobials. In this pilot study we will enroll 200 women post gynecologic surgery and randomize them to take either cranberry powder capsules or placebo powder capsules. The low risk of harm associated with using cranberry to reduce UTI coupled with its potential benefit makes it a desirable intervention for the prevention of CAUTI. The conduct/ results of this pilot /feasibility study will prepare us for the conduct of a large scale clinical trial.
Key facts
- Study ID
- NCT01346774
- Run by
- Betsy Foxman
- People needed
- 200
- Starts
- 2011-06-01
- Expected to finish
- 2013-10-01
- Last updated by the study team
- 2015-06-10
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Presenting at the gynecology clinic for a pre-operatory visit
- Ability to give informed consent
- Willing to take cranberry capsules for up to 6 weeks
- 18 of age or older
You may not qualify if…
- Pregnancy
- History of nephrolithiasis
- History of allergy to cranberry
- Patient on anticoagulant medicine to be re-started during the 4-6 weeks after surgery
- Less than 18 years old
Where it is running
- Urogynecology Clinic; University of Michigan — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.